FDA: we won’t regulate most apps
September 24, 2013Medical Communications, Sales and Marketing FDA, apps, iphone
Pandemrix narcolepsy U-turn by government
September 24, 2013Sales and Marketing GSK, Pandemrix, flu vaccine, government
The government has acknowledged that a GSK flu vaccine administered during the swine flu breakout could have caused children to …
Pharma makes progress on continuous processing
September 24, 2013Manufacturing and Production continuos processing, pharma
The drug industry has lagged behind other sectors in adopting more efficient manufacturing, but there are signs that one key …
Pfizer begins using ‘digital’ reps
September 24, 2013Medical Communications, Sales and Marketing Pfizer, online, pfizerline, reps
Pfizer has begun using digital drug representatives to market medicines, leaving the decision as to whether they want to see …
PAN promotes Sarah Verhoeff to Board director
September 24, 2013Medical Communications, Research and Development, Sales and Marketing Pan, verhoeff
Sarah Verhoeff who joined PAN in January has been promoted to director and joins the agency’s Board. Previously business director …
Boehringer and Ventana link up
September 24, 2013Research and Development, Sales and Marketing Boehringer, Ventana, oncology
Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …
Novartis backs new anti-malaria campaign
September 23, 2013Medical Communications, Sales and Marketing Novartis, donation, malaria
CHMP recommends cancer ‘smart bomb’
September 23, 2013Research and Development, Sales and Marketing CHMP, Cancer, EMA, Kadcyla, Roche
UK benefit halt for MMR jab refuseniks
September 23, 2013Sales and Marketing Labour, MMR, NHS, vaccination
Under new plans by the British Labour Party welfare payments could be stopped in the future for parents who fail …
Pfizer launches trial data sharing service
September 23, 2013Medical Communications, Sales and Marketing Pfizer, blue button
Pfizer has launched a first-of-its-kind project that enables patients who have participated in clinical trials the ability to download their …
GSK/Prosensa confirm orphan drug setback
September 23, 2013Sales and Marketing GSK, MD, Prosensa, drisapersen
An experimental treatment by GSK and Prosensa for a rare type of muscle-degenerating disease has failed to meet its primary …
Strengthening the pharma supply chain
September 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Last year’s discovery of fake versions of Roche’s cancer drug Avastin in the US supply chain served as a stark …
Perrigo appoints FDA director as regulatory head
September 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing perrigo. fda, webber
OTC healthcare products firm Perrigo Company has appointed the FDA’s Keith Webber to be its head of Regulatory Review. The …
FDA spends big on social media outlook
September 20, 2013Medical Communications, Sales and Marketing FDA, Facebook, PMCPA, Psoriasis 360, Twitter
Teva in Cancer Research UK tie-up
September 20, 2013Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
